ucsf logo

Prescott G. Woodruff, MD, MPH

Asthma • Chronic Obstructive Pulmonary Disease
Portrait of Prescott G. Woodruff
Portrait of Prescott G. Woodruff
ucsf logo

Prescott G. Woodruff, MD, MPH

Asthma • Chronic Obstructive Pulmonary Disease

On this page

About me

Dr. Prescott Woodruff specializes in pulmonary and critical care medicine. He also conducts research at UCSF's airway and general clinical research centers. He studies the mechanisms of inflammation, airway remodeling, and airway hyperresponsiveness (contraction or spasm in response to inhaled irritants) in asthma and chronic obstructive pulmonary disease (COPD).

Woodruff earned his medical degree at the Columbia Vagelos College of Physicians and Surgeons in New York City and completed a residency in internal medicine at Massachusetts General Hospital. After residency training, he was a research fellow in respiratory epidemiology at the Channing Laboratory at Brigham and Women's Hospital in Boston. He also completed a master of public health from the Harvard T.H. Chan School of Public Health and a fellowship in pulmonary and critical care medicine at UCSF. He joined the UCSF in 2002.

Woodruff is a member of the American Society for Clinical Investigation.

Education & training

Board certification

  • Critical Care Medicine, American Board of Internal Med/Critical Care Med
  • Pulmonary Disease, American Board of Internal Med/Pulmonary Disease

Residency

  • Internal Medicine, Massachusetts General Hospital

Internship

  • Internal Medicine, Massachusetts General Hospital

Degree

  • MD, Columbia College at Chicago

My expertise

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.